Company · CIK 1729214
XORTX Therapeutics Inc.
| CIK | 1729214 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | A1 |
| Business address | British Columbia, Canada |
| Listed | XRTX (Nasdaq) |
| First annual or quarterly report | 2022-05-03 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-290512 | 2025-09-25 | 2026-05-15 | 5 | |
| 333-269429 | 2023-01-27 | 2025-10-23 | 7 | |
| 333-283275 | 2024-11-15 | 2024-11-25 | 2 | |
| 333-258741 | 2021-08-12 | 2023-08-07 | 7 | |
| 333-267328 | 2022-09-08 | 2023-08-07 | 7 |
Filings
31| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-15 | 424B4Final prospectus | 333-290512 | 0001104659-26-062030 |
| 2026-05-13 | EFFECTDeclared effective | 333-290512 | 9999999995-26-001604 |
| 2026-02-17 | EFFECTDeclared effective | 333-290512 | 9999999995-26-000597 |
| 2026-02-13 | F-1/AAmendment | 333-290512 | 0001104659-26-014489 |
| 2025-10-23 | 424B5Shelf takedown | 333-269429 | 0001104659-25-101634 |
| 2025-09-25 | F-1Registration filed | 333-290512 | 0001104659-25-093362 |
| 2025-07-30 | DRSDraft made public | 377-08272 | 0001104659-25-072156 |
| 2024-12-13 | 424B5Shelf takedown | 333-269429 | 0001104659-24-128492 |
| 2024-11-25 | EFFECTDeclared effective | 333-283275 | 9999999995-24-003574 |
| 2024-11-15 | F-1Registration filed | 333-283275 | 0001104659-24-119763 |
| 2024-10-18 | 424B5Shelf takedown | 333-269429 | 0001104659-24-109674 |
| 2024-10-17 | 424B5Shelf takedown | 333-269429 | 0001104659-24-109381 |
| 2023-11-30 | 424B5Shelf takedown | 333-269429 | 0001104659-23-122148 |
| 2023-08-07 | EFFECTDeclared effective | 333-267328 | 9999999995-23-002292 |
| 2023-08-07 | EFFECTDeclared effective | 333-258741 | 9999999995-23-002289 |
| 2023-02-03 | EFFECTDeclared effective | 333-269429 | 9999999995-23-000280 |
| 2023-01-27 | F-3Shelf registered | 333-269429 | 0001104659-23-007219 |
| 2022-10-05 | 424B4Final prospectus | 333-267328 | 0001104659-22-106406 |
| 2022-09-30 | EFFECTDeclared effective | 333-267328 | 9999999995-22-002885 |
| 2022-09-22 | EFFECTDeclared effective | 333-267328 | 9999999995-22-002801 |
| 2022-09-21 | F-1/AAmendment | 333-267328 | 0001104659-22-101944 |
| 2022-09-12 | F-1/AAmendment | 333-267328 | 0001104659-22-099008 |
| 2022-09-08 | F-1Registration filed | 333-267328 | 0001104659-22-098458 |
| 2022-08-15 | DRSDraft made public | 377-06319 | 0001104659-22-090258 |
| 2021-10-14 | 424B4Final prospectus | 333-258741 | 0001753926-21-000570 |
| 2021-10-12 | EFFECTDeclared effective | 333-258741 | 9999999995-21-003848 |
| 2021-10-12 | F-1/AAmendment | 333-258741 | 0001753926-21-000563 |
| 2021-10-04 | F-1/AAmendment | 333-258741 | 0001753926-21-000527 |
| 2021-09-16 | F-1/AAmendment | 333-258741 | 0001753926-21-000445 |
| 2021-08-12 | F-1Registration filed | 333-258741 | 0001753926-21-000333 |
| 2021-05-26 | DRSDraft made public | 377-04929 | 0001753926-21-000167 |